U.K. lawmaker demands clinical trial transparency

A top member of British Parliament is championing clinical trial transparency: Norman Lamb, who chairs the legislature’s Science and Technology Committee, is calling for wayward companies, trial sponsors, and investigators to be penalized.

Lamb’s committee issued a blistering report last October on the woeful condition of trial transparency in the U.K., and he continues to be outspoken on the issue:

“An astounding amount of information from clinical trials is going unreported,” Lamb said in a statement. “Public trust in medicine could easily be eroded by these failings from such important parts of the health system.”